Precursor Cell Lymphoblastic Leukemia-Lymphoma  >>  hydrocortisone  >>  Phase 3
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
hydrocortisone / Generic mfg.
NCT00019409: Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia

Withdrawn
3
0
US, RoW
asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, mercaptopurine, methotrexate, prednisone, therapeutic hydrocortisone, vincristine sulfate, radiation therapy
National Institutes of Health Clinical Center (CC), National Cancer Institute (NCI)
Leukemia
 
07/01
NCT00002816: Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia

Completed
3
120
US, Canada, RoW
cytarabine, Cytosine Arabinoside, Ara-C, Cytosar-U, NSC-63878, dexamethasone, Decadron, NSC- 34521, etoposide, VP-16, VePesid, NSC-14154p, idarubicin, Idamycin, NSC-256439, ifosfamide, Ifex, NSC-109724, leucovorin calcium, mesna, Mesnex, NSC-113891, pegaspargase, PEG Asparaginase, PEG-ASP, K/H, KYOWA, HAKKO, NSC-644954, therapeutic hydrocortisone, thioguanine, vincristine sulfate, Oncovin, NSC-675574, low-LET cobalt-60 gamma ray therapy, low-LET electron therapy, low-LET photon therapy, Methotrexate, MTX, NSC-740
Children's Oncology Group, National Cancer Institute (NCI)
Leukemia
11/02
04/06
NCT00002700: Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia

Completed
3
392
Europe, RoW
asparaginase, cyclophosphamide, cytarabine, daunorubicin hydrochloride, dexamethasone, doxorubicin hydrochloride, leucovorin calcium, mercaptopurine, methotrexate, mitoxantrone hydrochloride, prednisolone, prednisone, therapeutic hydrocortisone, vincristine sulfate, allogeneic bone marrow transplantation, autologous bone marrow transplantation, radiation therapy
European Organisation for Research and Treatment of Cancer - EORTC, Acute Leukemia French Association
Leukemia, Lymphoma
03/04
 
NCT00165178: Treatment of Acute Lymphoblastic Leukemia in Children

Completed
3
498
US
prednisone, dexamethasone, doxorubicin, dexrazoxane, E. coli asparaginase, vincristine, methotrexate, Leucovorin, Asparaginase, cytarabine, ARA-C, Methotrexate/Hydrocortisone
Dana-Farber Cancer Institute, Boston Children's Hospital, University of Rochester, McMaster University, San Jorge Children's Hospital (Puerto Rico), St. Justine's Hospital, Maine Children's Cancer Program, Ochsner Health System, Tulane University School of Medicine, Laval University, Columbia University
Acute Lymphoblastic Leukemia
12/04
05/11
NCT00002744: Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia

Completed
3
1970
US, Canada, RoW
asparaginase, L-Asparaginase - Erwinia, NSC-106977, cyclophosphamide, Cytoxan, NSC-26271., cytarabine, Cytosine Arabinoside, Ara-C, Cytosar-U, daunorubicin hydrochloride, NSC-82151, dexamethasone, Decadron, NSC-34521, doxorubicin hydrochloride, Adriamycin, NSC-123127, mercaptopurine, 6-MP, Purinethol, methotrexate, NSC-740, pegaspargase, PEG Asparaginase, Oncaspar®, prednisone, NSC-10023, therapeutic hydrocortisone, thioguanine, 6-TG, NSC-752, vincristine sulfate, Oncovin, NSC-67574, low-LET cobalt-60 gamma ray therapy, low-LET photon therapy
Children's Oncology Group, National Cancer Institute (NCI)
Leukemia
03/07
03/07
NCT00004034: Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic Leukemia

Active, not recruiting
3
420
US, Canada
asparaginase, cytarabine, dexrazoxane hydrochloride, doxorubicin hydrochloride, leucovorin calcium, mercaptopurine, methotrexate, methylprednisolone, prednisolone, prednisone, therapeutic hydrocortisone, vincristine sulfate, quality-of-life assessment, radiation therapy
Dana-Farber Cancer Institute, National Cancer Institute (NCI)
Cardiac Toxicity, Leukemia
 
 
NCT01595048 / 2010-019224-31: Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia

Active, not recruiting
2/3
640
US, Canada, RoW
Rituximab, MOAB IDEC-C2B8, Prednisone, Etoposide, Lastet, Doxorubicin Hydrochloride, Cytarabine, CHX-3311, U-19920, Vincristine Sulfate, Kyocristine, Oncovin, VCR, Vincasar, Cyclophosphamide, Methotrexate, Methylprednisolone, MePRDL, Leucovorin Calcium, CF, Therapeutic Hydrocortisone, Aeroseb-HC, Cetacort, HC, Laboratory Biomarker Analysis
Children's Oncology Group, National Cancer Institute (NCI)
Childhood B Acute Lymphoblastic Leukemia, Childhood Burkitt Leukemia, Childhood Diffuse Large Cell Lymphoma, Mediastinal (Thymic) Large B-Cell Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma
12/20
12/20

Download Options